Corcept Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CORT and other ETFs, options, and stocks.About CORT
Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company. It engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol.
CORT Key Statistics
CORT News
Participants Atabak Mokari; Chief Financial Officer, Treasurer; Corcept Therapeutics Inc Gary Robb; Chief Business Officer, Secretary; Corcept Therapeutics In...
Revenue: Reported at $146.8 million, a 39% increase year-over-year, surpassing estimates of $141.20 million. Net Income: Reached $27.8 million, significantly e...
Corcept Therapeutics Inc. (CORT) just unveiled an update. Corcept Therapeutics Incorporated has announced its financial outcomes for the first quarter of 2024,...
More CORT News
Corcept Therapeutics Incorporated MENLO PARK, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage com...
Corcept Therapeutics announced completion of enrollment in CATALYST, a Phase 4 trial examining the prevalence of hypercortisolism in patients with difficult-to-...
Corcept Therapeutics Incorporated MENLO PARK, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage c...